Literature DB >> 11053685

Hereditary motor and sensory neuropathy-Lom (HMSNL) in a Spanish family: clinical, electrophysiological, pathological and genetic studies.

J Colomer1, C Iturriaga, L Kalaydjieva, D Angelicheva, R H King, P K Thomas.   

Abstract

The clinical, electrophysiological, pathological and genetic findings are described in the first Spanish family diagnosed with hereditary motor and sensory neuropathy type Lom (HMSNL) initially identified by Kalaydjeva et al. in 1996. The three affected patients belong to a non-consanguineous family with Gypsy background that were followed up over 10 years. Serial clinical and neurophysiological examinations and genetic analysis were undertaken in every patient. Sural nerve biopsy was performed in the oldest patient. The clinical features are similar to those previously described in HMSNL and all of them showed abnormal brain auditory evoked potentials. The oldest brother developed sensorineural deafness at the age of 20. Conduction velocities were unobtainable in all patients and nerves tested except for the median nerve in the youngest child in whom conduction was severely slowed. Neuropathological examination revealed a severely depleted nerve with very few surviving myelinated fibers which possessed thin myelin sheaths. Schwann cell processes were arranged in circular configurations without typical onion bulb configuration. Genetic analysis showed that the maternal chromosome inherited by all three affected siblings displayed a very unusual haplotype. Our patients show the characteristic clinical, electrophysiological and pathological findings described in HMSNL and represent the first reported Spanish family affected from the disease. The genetic findings in this family have contributed to refine the HMSNL critical linkage region.

Entities:  

Mesh:

Year:  2000        PMID: 11053685     DOI: 10.1016/s0960-8966(00)00149-8

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  8 in total

1.  N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom.

Authors:  L Kalaydjieva; D Gresham; R Gooding; L Heather; F Baas; R de Jonge; K Blechschmidt; D Angelicheva; D Chandler; P Worsley; A Rosenthal; R H King; P K Thomas
Journal:  Am J Hum Genet       Date:  2000-05-30       Impact factor: 11.025

2.  HMSN Lom in 12 Czech patients, with one unusual case due to uniparental isodisomy of chromosome 8.

Authors:  Dana Šafka Brožková; Jaroslava Paulasová Schwabová; Jana Neupauerová; Jana Sabová; Marcela Krůtová; Vladimír Peřina; Marie Trková; Petra Laššuthová; Pavel Seeman
Journal:  J Hum Genet       Date:  2016-12-22       Impact factor: 3.172

Review 3.  Neuropathology of Charcot-Marie-Tooth and related disorders.

Authors:  J Michael Schröder
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

4.  Aberrant Neuregulin 1/ErbB Signaling in Charcot-Marie-Tooth Type 4D Disease.

Authors:  Li-Ting Jiang; Yu-Hui Chen; Jie-Hong Huang; Wei-Fang Tong; Ling-Jing Jin; Li-Xi Li
Journal:  Mol Cell Biol       Date:  2022-06-16       Impact factor: 5.069

5.  Autosomal recessive forms of Charcot-Marie-Tooth disease.

Authors:  J M Vallat; D Grid; C Magdelaine; F Sturtz; M Tazir
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

6.  Hereditary motor and sensory neuropathy Lom type in a Serbian family.

Authors:  J Dacković; M Keckarević-Marković; Z Komazec; V Rakocević-Stojanović; D Lavrnić; Z Stević; K Ribarić; S Romac; S Apostolski
Journal:  Acta Myol       Date:  2008-10

7.  Genetic studies of the Roma (Gypsies): a review.

Authors:  L Kalaydjieva; D Gresham; F Calafell
Journal:  BMC Med Genet       Date:  2001-04-02       Impact factor: 2.103

8.  Exonic duplication CNV of NDRG1 associated with autosomal-recessive HMSN-Lom/CMT4D.

Authors:  Yuji Okamoto; Meryem Tuba Goksungur; Davut Pehlivan; Christine R Beck; Claudia Gonzaga-Jauregui; Donna M Muzny; Mehmed M Atik; Claudia M B Carvalho; Zeliha Matur; Serife Bayraktar; Philip M Boone; Kaya Akyuz; Richard A Gibbs; Esra Battaloglu; Yesim Parman; James R Lupski
Journal:  Genet Med       Date:  2013-10-17       Impact factor: 8.822

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.